 | Print this page |
|
| |
ANNOUNCEMENTS
Glenmark Pharmaceuticals net profit declines 24.34% in the June 2012 quarter
Sales rise 20.72% to Rs 390.28 crore
Net profit of Glenmark Pharmaceuticals declined 24.34% to Rs 54.83 crore in the quarter ended June 2012 as against Rs 72.47 crore during the previous quarter ended June 2011. Sales rose 20.72% to Rs 390.28 crore in the quarter ended June 2012 as against Rs 323.30 crore during the previous quarter ended June 2011.
In the consolidated results,net profit declined 62.47% to Rs 78.28 crore in the quarter ended June 2012 as against Rs 208.59 crore during the previous quarter ended June 2011.Sales rose 19.83% to Rs 1040.41 crore in the quarter ended June 2012 as against Rs 868.25 crore during the previous quarter ended June 2011.
| Particulars | Quarter Ended | ||
| Jun. 2012 | Jun. 2011 | % Var. | |
| Sales | 390.28 | 323.30 | 21 |
| OPM % | 16.82 | 32.69 | -49 |
| PBDT | 67.15 | 96.42 | -30 |
| PBT | 61.08 | 91.45 | -33 |
| NP | 54.83 | 72.47 | -24 |
| Previous Stories |
|
| More 4 |